Conditions: Esophageal Cancer
Intervention Type: Drug
Intervention Name: romidepsin
Clinical Trials
The following are clinical trials from the Healia Clinical Trials Information Database that are researching the effect of the "Drug" intervention "romidepsin" on "Esophageal Cancer".
-
A Phase 2 Study of Single Agent Depsipeptide (FK228) in Gastric and Esophageal Cancers
NCTID: NCT00098527
-
Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion in Subjects With Pulmonary and Pleural Malignancies
NCTID: NCT00041158
-
Phase I Study Of Sequential Depsipeptide/Flavopiridol Infusion for Malignancies Involving Lungs, Esophagus, Pleura or Mediastinum
NCTID: NCT00098644